Elimination of activated but not resting primary human CD4⁺ and CD8⁺ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells

By Hoves Sabine   Krause Stefan W.   Herfarth Hans   Halbritter Dagmar   Zhang Huang-Ge   Mountz John D.   Schölmerich Jürgen   Fleck Martin  

Immunobiology, Vol. 208, Iss. 5, 2004-03 ,pp. : 463-475

Urban & Fischer

Access to resources Recommend Favorite

Correlation of Loss of CD4 T Cells with Plasma Levels of Both Soluble Form Fas (CD95) and Fas Ligand (FasL) in HIV-Infected Infants

By Hosaka N.   Oyaizu N.   Than S.   Pahwa S.  

Clinical Immunology, Vol. 95, Iss. 1, 2000-04 ,pp. : 20-25

Academic Press

Access to resources Recommend Favorite

CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism - a functional role for the 50 kD T11sheep erythrocyte receptor protein

By Daniel P.T.   Scholz C.   Eszmann F.   Westermann J.   Pezzutto A.   Dorken B.  

Experimental Hematology, Vol. 27, Iss. 9, 1999-09 ,pp. : 1402-1408

Elsevier

Access to resources Recommend Favorite

IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4 + and CD8 + effector-memory T cells

By Mueller Y.M.  

International Immunology, Vol. 15, Iss. 1, 2003-01 ,pp. : 49-58

Oxford University Press

Access to resources Recommend Favorite

CD40FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism

By Dranitzki-Elhalel M.   Huang J. H.   Sasson M.   Rachmilewitz J.   Parnas M.   Tykocinski M. L.  

International Immunology, Vol. 19, Iss. 4, 2007-04 ,pp. : 355-363

Oxford University Press

Access to resources Recommend Favorite